(45) reported that downregulation of lncRNA FUNDC2P4 promoted EMT, leading to proliferation, invasion, and migration of tumor cells by reducing expression of E-cadherin in residual HCC after RFA, which suggests that FUNDC2P4 may have value for prevention and treatment of recurrent HCC. This evidence concerns the gene CDH1 and hepatocellular carcinoma.